Cannabinoid derivatives induce cell death in pancreatic MIA PaCa‐2 cells via a receptor‐independent mechanism

Citations Over TimeTop 10% of 2006 papers

Abstract

Cannabinoids (CBs) are implicated in the control of cell survival in different types of tumors, but little is known about the role of CB system in pancreatic cancer. Herein, we investigated the in vitro antitumor activity of CBs and the potential role of their receptors in human pancreatic cancer cells MIA PaCa‐2. Characterization tools used for this study included growth inhibition/cell viability analyses, caspase 3/7 induction, DNA fragmentation, microarray analysis and combination index‐isobologram method. Our results demonstrate that CBs produce a significant cytotoxic effect via a receptor‐independent mechanism. The CB 1 antagonist N ‐(piperidin‐1‐1yl)‐5‐(4‐iodophenyl)‐1‐(2,4‐dichlorophenyl)‐4‐methyl‐1 H ‐pyrazole‐3‐carboxamide (AM251) was the most active compound with an IC 50 of 8.6 ± 1.3 μM after 72 h. AM251 induces apoptosis, causes transcriptional changes of genes in janus kinase/signal transducers and activators of transcription signaling network and synergistically interacts with the pyrimidine analogue, 5‐fluorouracil. These findings exclude the involvement of CB receptors in the regulation of MIA PaCa‐2 cell growth and put AM251 forward as a candidate for the development of novel compounds worthy to be tested in this type of neoplasia.

Related Papers

• → Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors(1997)142 cited
• → Activation of cannabinoid CB1 receptors induces glucose intolerance in rats(2006)109 cited
• → Role of Cannabinoid and Vanilloid Receptors in Invasion of Human Breast Carcinoma Cells(2012)23 cited
• → Species and strain differences in the expression of a novel glutamate‐modulating cannabinoid receptor in the rodent hippocampus(2005)59 cited
• P 9: Neuoprotective Effect of Cannabinoid CB1 Receptor Antagonists Rimonabant and AM251 on Hypoxic Mouse Model of Brain Oxidative Stress(2017)